Rigel Pharmaceuticals, Inc. · NASDAQ:RIGL
Armistice Capital, LLC reported a 8.48% stake in Rigel Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Armistice Capital, LLC reported a 8.48% stake in Rigel Pharmaceuticals, Inc., 1,516,000 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 8.48%
- Shares
- 1,516,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 8.48% | 1,516,000 |
| Steven Boyd | 8.48% | 1,516,000 |
Source
Related
- Rigel Pharmaceuticals, Inc.
- Armistice Capital, LLC
- Rigel Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G · Armistice Capital, LLC · May 15, 2026
- Schedule 13G/A · Armistice Capital, LLC · Feb 14, 2025
- Form 4 · Schorno Dean L · Sep 3, 2026
- Form 4 · Santos David A · Sep 3, 2026
- Form 4 · Rodriguez Raul R · Sep 3, 2026
- Form 4 · Furey Raymond J. · Sep 3, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Aug 13, 2026